Edition:
India

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

10.48USD
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
$10.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,844
52-wk High
$39.85
52-wk Low
$10.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -2.184
Mar '17 0.00 -2.201
FY 2016 Dec '16 61.24 -2.499
Sep '16 28.07 -2.327
Jun '16 0.00 -4.076
Mar '16 0.00 -3.234
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 209.45
Earnings (per share)
Quarter Ending Mar-18 1 -1.03 -1.03 -1.03 --
Quarter Ending Jun-18 1 -1.12 -1.12 -1.12 --
Year Ending Dec-18 3 -5.44 -4.26 -7.62 -0.77
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 61.64 44.53 33.35
EPS (TTM) % 8.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Merrimack Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.99%
# of Holders: 124
Total Shares Held: 6,932,396
3 Mo. Net Change: -31,736
# New Positions: 3
# Closed Positions: 5
# Increased Positions: 4
# Reduced Positions: 7
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.